There are currently two approved drugs in the oral SERD class, namely Menarini/Stemline's Orserdu (elacestrant) and Eli Lilly ...

An NHS trust in the UK has become the first site in Europe to offer Roche's experimental drug trontinemab to patients ...

The milestones in xenotransplantation – cross-species transplants – rely on cutting-edge biotechnologies, including the use ...

Novartis has paused eight clinical trials of its experimental CAR-T therapy rapcabtagene autoleucel (rap-cel or YTB323) after ...

The discovery by the UK Health Security Agency (UKHSA) raises the possibility that viral diseases that are known to be ...

Editor's Note: pharmaphorum is an editorially independent publication owned by EVERSANA.

Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in relapsing multiple sclerosis (RMS ...

Ionis' antisense therapy Zanvastro has been approved by the FDA for Alexander disease (AxD), throwing a lifeline to people ...

The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity ...

PMV Pharma is preparing to file for approval of its oral p53 protein reactivator drug rezatopopt in the first quarter of 2027 ...

Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT ...